PRPH
NSCProPhase Labs Inc.
Healthcare•Drug Manufacturers - Major
Watchlists:
Last updated: Friday 18th July 2025
0.37
+0.00 (0.38%)
Prev Close:0.372
Open:0.372
Bid:0.3561
Ask:0.386
52 Week Range
0.223.37
Volume:2,160,418
Mkt Cap:17 M
40
MarketXLS Rank ®
Hold
Price Target
$0.43
+15.2%
Financial Statements
PRPH - Income Statement (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Basic Discontinuous Operations | -0.19 | 0.02 | -0.01 | 2.75 | 0.07 | |||||
| Depreciation And Amortization | 6 M | 6 M | 5 M | 2 M | 375000.0 | -398000.0 | -383000.0 | -337000.0 | -426000.0 | -367000.0 |
| Development Expense | -300000.0 | -300000.0 | ||||||||
| Diluted Discontinuous Operations | -0.19 | -0.01 | 2.73 | 0.07 | ||||||
| Fees | 2000.0 | |||||||||
| Gain On Sale Of PPE | 2 M | |||||||||
| Gain On Sale Of Security | -76000.0 | -240000.0 | 4000.0 | 22000.0 | 54000.0 | |||||
| Gains Loss On Disposal Of Discontinued Operations | 201000.0 | -40000.0 | -340000.0 | 43 M | 1 M | |||||
| General And Administrative Expense | 38 M | 35 M | 46 M | 22 M | 7 M | 4 M | 5 M | 5 M | 3 M | 7 M |
| Gross Profit Margin (profit Margin After CGS) | -150000.0 | 16 M | 71 M | 42 M | 5 M | 3 M | 5 M | 2 M | 997000.0 | 12 M |
| Interest Expense Non Operating | 399000.0 | 259000.0 | 764000.0 | 1 M | 295000.0 | 54000.0 | 213000.0 | 18000.0 | ||
| Interest Income Operating | 642000.0 | 62000.0 | ||||||||
| Marketing Expense | -443000.0 | -264000.0 | -10 M | -8 M | ||||||
| Misc Other Special Charges | -351000.0 | 10000.0 | 150000.0 | 187000.0 | ||||||
| Net Income (loss) | -53 M | -17 M | 18 M | 6 M | -2 M | -3 M | -2 M | 41 M | -3 M | -4 M |
| Net Income Common Stockholders | -53 M | -17 M | 18 M | 6 M | -1 M | -3 M | -2 M | 41 M | -3 M | -4 M |
| Net Income Continuous Operations | -50 M | -16 M | 18 M | 6 M | -2 M | -3 M | -2 M | 41 M | -3 M | -4 M |
| Net Income Discontinuous Operations | -4 M | -402000.0 | 201000.0 | -40000.0 | -340000.0 | 43 M | 1 M | |||
| Net Non Operating Interest Income Expense | -399000.0 | 78000.0 | -611000.0 | -506000.0 | -233000.0 | 133000.0 | 167000.0 | 177000.0 | -212000.0 | -16000.0 |
| Normalized Income | -42 M | 4 M | ||||||||
| Operating Income | -39 M | -21 M | 24 M | 10 M | -2 M | -3 M | -2 M | -4 M | -4 M | -4 M |
| Operating Income Before Depreciation (EBITDA) | -34 M | -16 M | 29 M | 10 M | -2 M | -3 M | -1 M | -3 M | -3 M | -3 M |
| Operating Expense | 38 M | 37 M | 47 M | 32 M | 9 M | 6 M | -6 M | -6 M | -5 M | -16 M |
| Other Gain Loss From Disposition Of Discontinued Operations | -4 M | -402000.0 | 201000.0 | |||||||
| Other Gand A | 38 M | 35 M | 46 M | 22 M | 7 M | 4 M | 5 M | 5 M | 3 M | 7 M |
| Other Operating Expenses | 956000.0 | 956000.0 | 816000.0 | -9 M | -448000.0 | -152000.0 | ||||
| Other Write Off | 39000.0 | -724000.0 | -5 M | |||||||
| Rent And Landing Fees | 5 M | 5 M | 3 M | 7 M | ||||||
| Research Expense | 600000.0 | 1 M | 700000.0 | 500000.0 | 633000.0 | 332000.0 | 398000.0 | 431000.0 | 358000.0 | 1 M |
| Restructring And Mn A Income | -6 M | -6 M | -2 M | -228000.0 | ||||||
| Salaries And Wages | 4 M | 4 M | 1 M | -744000.0 | -590000.0 | -78000.0 | -1000.0 | -135000.0 | ||
| Selling And Marketing Expense | 1 M | 1 M | 1 M | 699000.0 | 2 M | 8 M | ||||
| Selling Expense | 1 M | 1 M | 699000.0 | 2 M | 8 M | |||||
| Total Income Available For Interest Expense (EBIT) | -42 M | -22 M | 24 M | 6 M | -2 M | -3 M | -1 M | -4 M | -4 M | -4 M |
| Total Revenues | 7 M | 35 M | 123 M | 79 M | 15 M | 10 M | 13 M | 10 M | 4 M | 21 M |
| Total Expenses | 45 M | 56 M | 99 M | 69 M | 18 M | 13 M | -15 M | -14 M | -8 M | -24 M |
| Total Revenue | 7 M | 35 M | 123 M | 79 M | 15 M | 10 M | 13 M | 10 M | 4 M | 21 M |
| Amord | 4 M | 4 M | 2 M | 6 M | 974000.0 | |||||
| Avgshs | 20 M | 17 M | 16 M | 15 M | 12 M | 12 M | 11 M | 16 M | 17081.0 | 16 M |
| Avgshsdt | 20 M | 17 M | 19 M | 18 M | 12 M | 12 M | 16 M | 17081.0 | 16 M | |
| Basiceps | -2.61 | -0.98 | 1.17 | 0.82 | -0.36 | -0.15 | 2.61 | -0.17 | -0.22 | |
| Basicepscont | -2.42 | -0.98 | 1.17 | 0.82 | -0.38 | -0.14 | -0.14 | -0.24 | -0.22 | |
| Cor | 7 M | 19 M | 52 M | 37 M | 10 M | 7 M | -8 M | -8 M | -3 M | -8 M |
| Depamor | 6 M | 6 M | 5 M | 2 M | 375000.0 | -398000.0 | -383000.0 | -337000.0 | -426000.0 | -367000.0 |
| Dileps | -2.61 | -0.98 | 1.02 | 0.8 | -0.36 | -0.27 | -0.15 | 2.59 | -0.17 | -0.22 |
| Dilepscont | -2.42 | -0.98 | 1.02 | 0.8 | -0.27 | -0.14 | -0.14 | -0.24 | -0.22 | |
| Intinc | 78000.0 | 153000.0 | 642000.0 | 62000.0 | 133000.0 | 167000.0 | 177000.0 | 1000.0 | 2000.0 | |
| Netincdisc | -53 M | -17 M | 18 M | 6 M | -2 M | -3 M | -2 M | 41 M | -3 M | -4 M |
| Othincexp | 351000.0 | -10000.0 | -76000.0 | 404000.0 | -2 M | -22000.0 | -54000.0 | -150000.0 | -187000.0 | |
| Pretaxinc | -42 M | -22 M | 23 M | 5 M | -2 M | -3 M | -1 M | -4 M | -4 M | -4 M |
| Resdev | 600000.0 | 1 M | 700000.0 | 500000.0 | 633000.0 | 332000.0 | 398000.0 | 431000.0 | 358000.0 | 1 M |
| Restruct | -6 M | -6 M | -2 M | -228000.0 | ||||||
| Sga | 38 M | 35 M | 46 M | 22 M | 7 M | 6 M | 6 M | 6 M | 4 M | 15 M |
| Shsout | 42 M | 18 M | 17 M | 15 M | 15 M | 12 M | 12 M | 11 M | 17 M | 17 M |
| Specincchg | 6 M | 6 M | 2 M | 228000.0 | ||||||
| Taxprov | 7 M | -6 M | 4 M | -968000.0 | 12000.0 | 7000.0 | 103000.0 | -1 M | 1 M | 1 M |